Anavar: The Mildest Oral AAS — Educational Reference
Last updated: March 2026
Oxandrolone (Anavar) is an FDA-approved oral anabolic-androgenic steroid with a uniquely favorable anabolic-to-androgenic ratio. This educational reference covers its pharmacology, documented clinical applications in muscle wasting and burn recovery, hepatotoxicity risks, and suppression profile for harm reduction.
(androgenic ~24% of testosterone)
2.5–10mg/day in women
Once or twice daily dosing
📋 On this page
How Oxandrolone Works
Oxandrolone is a synthetic DHT derivative with a unique modification: an oxygen atom replaces the carbon-2 in the A-ring, increasing anabolic potency while dramatically reducing androgenic activity. The C-17α methyl group enables oral bioavailability.
Oxandrolone binds androgen receptors with high affinity in muscle tissue. The 2-oxa modification creates a uniquely anabolic-selective compound — anabolic:androgenic ratio of approximately 322–630:24 vs testosterone's 100:100 baseline. This selectivity is why it's one of the few AAS with legitimate FDA-approved clinical applications and a safer profile in women.
As a dihydrotestosterone derivative, oxandrolone cannot be aromatized to estrogen. There is no estrogenic activity, no water retention, and no gynecomastia risk from estrogen conversion. This makes it one of the cleanest AAS for lean tissue preservation without estrogenic side effects — though androgenic effects like DHT-related hair loss remain possible.
Despite its mild reputation, oxandrolone is 17α-alkylated and genuinely hepatotoxic. Elevated ALT and AST are common, particularly at higher doses or extended cycles. The liver stress is dose and duration dependent. "Mild" refers to its androgenic and estrogenic profile — not liver safety. Cycle lengths should be limited to 6–8 weeks with liver support.
Oxandrolone suppresses the hypothalamic-pituitary-testicular axis, though less severely than most other oral AAS. Endogenous LH and FSH are reduced, leading to decreased natural testosterone production. Recovery tends to be faster than with stronger androgens, but PCT with SERMs is still standard practice after cycles longer than 4 weeks in men.
What Clinical Literature Shows
Data from published clinical trials on oxandrolone — including FDA-approved indications for muscle wasting, burn recovery, and Turner syndrome.
Side Effects & Risks
Key Takeaways
- FDA-approved for muscle wasting, burn recovery, Turner syndrome, and HIV wasting
- Anabolic:androgenic ratio of ~322–630:24 — exceptionally anabolic-selective
- Does not aromatize — no estrogen-related side effects
- 9–10 hour half-life allows once or twice daily dosing
- Still hepatotoxic — 17α-alkylation causes liver enzyme elevation
- Lowest virilization risk among oral AAS — most studied AAS in women
- Milder HPTA suppression than Dianabol, Anadrol, or Winstrol
- Cycle lengths limited to 6–8 weeks to minimize liver impact
- Long-term cardiovascular outcomes in recreational bodybuilding doses poorly documented
- Optimal TUDCA/NAC dosing for oxandrolone-specific hepatoprotection not established by RCT
- Individual variation in 17α-methylation metabolism creates unpredictable hepatotoxicity
- Exact virilization threshold dose in women — irreversible effects possible
- "Mild" label creates dangerous underestimation of real hepatic and lipid risks
🛒 Liver Support & Monitoring
Any oral AAS cycle requires liver support and regular bloodwork. Don't skip these harm reduction basics — "mild" doesn't mean liver-safe.
Related Resources
Want the Complete Protocol Guide?
Dosing schedules, interaction warnings, and cycle protocols for 50+ compounds — all in one place.
Get the Guide →
This page is for educational and harm reduction purposes only. It is not medical advice. Oxandrolone (Anavar) is a Schedule III controlled substance in the United States under the Anabolic Steroid Control Act of 1990. Possession, distribution, or use without a valid prescription is illegal and carries serious legal penalties. Anabolic steroids carry significant health risks including liver damage, cardiovascular disease, and hormonal disruption. Always consult a qualified physician before making any decisions regarding hormone use. HighPeptides does not endorse or encourage the use of controlled substances.